Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness and Safety of Omnipod 5 in Adults With Type 1 Diabetes: a 12-month Observational Study.

NCT07696039 is registered in ClinicalTrials.gov with Papa Giovanni XXIII Hospital as lead sponsor.

NCT NCT07696039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07696039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness and Safety of Omnipod 5 in Adults With Type 1 Diabetes: a 12-month Observational Study.
Lead sponsor
Papa Giovanni XXIII Hospital
Phase
Observational
Overall status
Completed
Start date
January 7, 2026
Completion date
June 30, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus